These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8484676)
21. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Campos LM; Kiss MH; D'Amico EA; Silva CA Lupus; 2003; 12(11):820-6. PubMed ID: 14667097 [TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid syndrome: review. Sammaritano LR South Med J; 2005 Jun; 98(6):617-25; quiz 626-7, 645. PubMed ID: 16004169 [TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies: method of detection. Harris EN; Pierangeli S Am J Reprod Immunol; 1992; 28(3-4):208-10. PubMed ID: 1285880 [TBL] [Abstract][Full Text] [Related]
25. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance. Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576 [TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid syndrome and the skin. Gibson GE; Su WP; Pittelkow MR J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):970-82. PubMed ID: 9204065 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Quereda C; Otero GG; Pardo A; Orte L; Rivera M; Gonzalo A; Pascual J; Ortuño J Am J Kidney Dis; 1994 Apr; 23(4):555-61. PubMed ID: 8154492 [TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
30. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
31. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Roubey RA Lupus; 1996 Oct; 5(5):425-30. PubMed ID: 8902774 [TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. Santos TDS; Ieque AL; de Carvalho HC; Sell AM; Lonardoni MVC; Demarchi IG; de Lima Neto QA; Teixeira JJV J Reprod Immunol; 2017 Sep; 123():78-87. PubMed ID: 28985591 [TBL] [Abstract][Full Text] [Related]
33. Antibody profiles for the diagnosis of antiphospholipid syndrome. Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401 [TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460 [TBL] [Abstract][Full Text] [Related]
36. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous manifestations in antiphospholipid syndrome. Caporuscio S; Sorgi ML; Nisticò S; Pranteda G; Bottoni U; Carboni I; Del Duca E; Pranteda G Int J Immunopathol Pharmacol; 2015 Jun; 28(2):270-3. PubMed ID: 25875603 [TBL] [Abstract][Full Text] [Related]
38. [Anti-phospholipid syndrome nephropathy]. Nochy D; Daugas E; Hill G; Piette JC Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659 [TBL] [Abstract][Full Text] [Related]
39. Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Hodak E; Feuerman H; Molad Y; Monselise Y; David M Lupus; 2003; 12(7):564-8. PubMed ID: 12892400 [TBL] [Abstract][Full Text] [Related]